Repatha 140 mg/mL single-dose prefilled syringe Images
Generic Name: evolocumab
This medication has been identified as Repatha 140 mg/mL single-dose prefilled syringe. It is supplied by Amgen Inc.
Repatha is used in the treatment of Cardiovascular Risk Reduction; High Cholesterol, Familial Heterozygous; High Cholesterol; High Cholesterol, Familial Homozygous and belongs to the drug class PCSK9 inhibitors. Repatha 140 mg/mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Repatha
- Generic Name
- evolocumab
- Strength
- 140 mg/mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- PCSK9 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 72511-0750
More about Repatha (evolocumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (602)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: PCSK9 inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
